NEW YORK ( TheStreet) -- CHANGE IN RATINGSBP ( BP) was upgraded to buy at TheStreet Ratings. CVS Caremark ( CVS) was downgraded at Cantor Fitzgerald to hold from buy. Valuation call, based on a $62 price target, Cantor said. Fiserv ( FISV) was upgraded at Sterne Agee to buy from neutral. $120 price target. Company should deliver higher internal sales growth this year, given better end-market conditions, Sterne Agee said. Fossil ( FOSL) was downgraded at Citigroup to neutral from buy. Based on valuation and despite global growth opportunity, said Citi. Price target goes to $135.
McDermott ( MDR) was downgraded at DA Davidson to neutral from buy. $7.25 price target. Losses are broadening, DA Davidson said. Mead Johnson ( MJN) was upgraded at Credit Suisse to outperform from neutral. $90 price target. Company should benefit from competitor recalls, Credit Suisse said. Marathon Oil ( MRO) was downgraded at Bank of America/Merrill Lynch to neutral. Valuation call, based on a $42 price target, BofA/Merrill said. OneBeacon ( OB) was downgraded to hold at TheStreet Ratings. Yum! Brands ( YUM) was upgraded at Bank of America/Merrill Lynch to neutral from underperform. $79 price target. Market is more willing than expected to look through China issues, BofA/Merrill said.
AECOM Technology ( ACM) numbers were cut at UBS. Estimates were reduced as backlog conversion is taking longer than expected, said UBS. Price target is reduced to $33. American International ( AIG) numbers were increased at BMO Capital. Estimates were raised through 2014. Business turnaround is on course, BMO Capital said. Outperform rating and new $55 price target. BlackRock ( BLK) price target was raised at Citigroup to $285. The company remains on message with regard to positioning, organic growth, margins and capital returns, Citi said. Charles River Laboratories ( CRL) price target was raised at Jefferies to $57. Company is a relative value with an improving outlook in a CRO sector with very high investor enthusiasm, Jefferies said. Buy rating.